Skip to content

Medicines reconciliation at the interface

Medicines reconciliation at the interface: a pilot randomised controlled trial to determine the costs and effects of a pharmacy provided service

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN23949491
Enrollment
200
Registered
2012-09-10
Start date
2012-07-04
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Services Research Not Applicable

Interventions

Medicines reconciliation versus medicines reconciliation within 24 hours of admisssion by the Study Pharmacist. Followed up at 3 months.

Sponsors

Cambridge University Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult, aged at least 18 years of age 2. Admitted with prescribed medicines (at least one regular/OTC medication ) to one of the five adult medical wards. 3. Not received MR service from the pharmacy team as part of routine pharmaceutical input at the point of recruitment. 4. Identified from hospital computer system as being admitted within the previous 24 hours 5. Male or female participants

Exclusion criteria

Exclusion criteria: 1. Elective patients receive MR via pre-admission clinics such as surgical pre admission assessment unit 2. Wards anticipated to close during the study period will be automatically excluded 3. Recruited patients readmitted during the course of the study

Design outcomes

Primary

MeasureTime frame
Length of stay measured at discharge

Secondary

MeasureTime frame
1. Feasibility measured at end of study 2. Morbidity and mortality measured at 3 months 3. Patient satisfaction measured at 3 months 4. Quality of life measured at 3 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 27, 2026